ArticleCurrent oncology (Toronto, Ont.)2015
Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 1: prophylaxis.
Article in Current oncology (Toronto, Ont.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 3 syntheses or guidelines pooled it, 71 citations in OpenAlex.
- Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia.The Cochrane database of systematic reviews · 2020Pooled it
- The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTH.Journal of thrombosis and haemostasis : JTH · 2019Guideline
- Pooled it
- Management of Patients Receiving Anticoagulation Therapy in Dental Practice: A Systematic Review.Healthcare (Basel, Switzerland) · 2024Review
- A Systematic Review of the Guidelines on Venous Thromboembolism Prophylaxis in Gynecologic Oncology.Cancers · 2022Review
- Early warning prevention and control strategies to reduce perioperative venous thromboembolism in patients with gastrointestinal cancer.World journal of clinical cases · 2022Article
- Review
- Review
- Management of anticoagulation in patients with metastatic castration-resistant prostate cancer receiving abiraterone + prednisone.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2019Review
- Article
- Recent advances in the treatment and prevention of venous thromboembolism in cancer patients: role of the direct oral anticoagulants and their unique challenges.F1000Research · 2019Review
- [Perioperative Venous Thromboembolism (VTE) Prophalaxis in Thoracic Cancer Patients: Chinese Experts Consensus].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2018Article
- The Society for Translational Medicine: the assessment and prevention of venous thromboembolism after lung cancer surgery.Journal of thoracic disease · 2018Review
- The use of prophylactic anticoagulation during induction and consolidation chemotherapy in adults with acute lymphoblastic leukemia.Journal of thrombosis and thrombolysis · 2018Article
- FOTROCAN Delphi consensus statement regarding the prevention and treatment of cancer-associated thrombosis in areas of uncertainty and low quality of evidence.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2017Article
- Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study.The oncologist · 2017Article
- High risk of deep vein thrombosis associated with peripherally inserted central catheters in lymphoma.Oncotarget · 2016Article
- Prevention and Treatment of Venous Thromboembolism in Patients with Cancer: Focus on Drug Therapy.Drugs · 2016Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors at 9 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Patients with cancer are at increased risk of venous thromboembolism (vte). Anticoagulation therapy has been shown to prevent vte; however, unique clinical circumstances in patients with cancer can often complicate the decisions surrounding the administration of prophylactic anticoagulation. No national Canadian guidelines on the prevention of cancer-associated thrombosis have been published. We therefore aimed to develop a consensus-based, evidence-informed guideline on the topic. PubMed was searched for clinical trials and meta-analyses published between 2002 and 2013. Reference lists of key articles were hand-searched for additional publications. Content experts from across Canada were assembled to review the evidence and make recommendations. Low molecular weight heparin can be used prophylactically in cancer patients at high risk of developing vte. Direct oral anticoagulants are not recommended for vte prophylaxis at this time. Specific clinical scenarios, including renal insufficiency, thrombocytopenia, liver disease, and obesity can warrant modifications in the administration of prophylactic anticoagulant therapy. There is no evidence to support the monitoring of anti-factor Xa levels in clinically stable cancer patients receiving prophylactic anticoagulation; however, factor Xa levels could be checked at baseline and periodically in patients with renal insufficiency. The use of anticoagulation therapy to prolong survival in cancer patients without the presence of risk factors for vte is not recommended.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.